Insightful Session with Dr Ausra Baradoke, Founder and CEO of Deep Scientific In a recent interview, Dr Ausra Baradoke, the Founder and CEO of Deep Scientific, discussed with Muhammad Younis some pivotal subjects, including the groundbreaking potential of biosensors in disease detection
Precision Medicine: Revolutionising Healthcare Globally Introduction Precision Medicine, a cutting-edge approach in healthcare, is reshaping the way we perceive and treat diseases. In this article, we will delve into the intricacies of precision medicine, exploring
Interview with Rob Drury-Dryden, Consultant, Precision Biopharma Consultancy In a recent interview with Muhammad Younis, Rob Drury-Dryden, Consultant at Precision Biopharma Consultancy, delved into some pivotal topics: Omics, a field encompassing genomics, proteomics, and other -omics, revolutionizing precision
The Transformative Power of Big Data and AI in the Biotechnology Industry Today, artificial intelligence (AI) and big data are rapidly revolutionising every industry, including the biotechnology sector. These cutting-edge technologies are driving innovation and transformation, leading to the development of novel
Enlightening Session with Herna De Wit, Head of Bioscience at Human Edge Are biotech advancements reshaping healthcare by directly targeting the core processes of ageing, promising longevity and a bolstered state of health? In a recent interview, Herna De Wit, Head of
Glox Therapeutics Raises £4.3m Seed Funding To Combat Drug-Resistant Bacteria With Precision Antimicrobials Glasgow, UK, 14 Nov, 2023: Glox Therapeutics, the company at the forefront of crafting precise antibiotic treatments derived from natural bacteriocins, has secured £4.3 million in initial funding. This
Insightful session with Sheldon Caref, President at BioAgro Science for Life Bioagro, a facet of Biotechnology, presents a compelling alternative to traditional chemical farming practices. In a recent interview, Sheldon Caref, President at BioAgro Science for Life, discussed with Muhammad Younis
Interview with Pierre Cressard, Co-founder and CEO of Nahibu. In a recent interview, Pierre Cressard, Co-founder and CEO of Nahibu, a global microbiome company, talked with Muhammad Younis about the pivotal role of the microbiome in shaping the overall
Enlightening Session with Georges Rawadi, CEO at Celyad Oncology The landscape of gene and cell therapies is undergoing a significant transformation as regulatory bodies across different countries are actively improving their practices, guidelines, and human resources to accommodate the
Scientists Create Self-Healing, Antimicrobial Material That Could Revolutionise Human Tissue Growth 24 Oct, 2023: Scientists at UNSW Sydney have created an innovative substance that has the capacity to transform the methods for cultivating human tissue in laboratory settings and employing it
Insightful Session with for Laiqha Khadri, Founder of Immune-Inspired Health Consulting Cancer stands as one of the gravest health challenges globally. In the quest to combat this formidable disease, biotechnology emerges as a beacon of hope on the horizon. During a
Interview with Sarunas (George) Baciliunas, Co-Founder and Chief Executive Officer at Integral Solutions The Gut Microbiome plays a vital role in determining mental health. In a recent interview, Sarunas (George) Baciliunas, Co-Founder and CEO of Integral Solutions, discussed with Muhammad Younis the intricate
Explore The Future Of Healthcare With The Incredible Line Of Speakers At The London Biotechnology Show As the field of biotechnology continues to advance, it is the voice and insights of the experts that drive innovation, shape the industry, and offer a vision of what the
Innovative 3D Printing Method Offers Hope For Brain Injury Treatment 04 Oct, 2023: Scientists at the University of Oxford have used 3D printing technology to create engineered tissue that mimics a simplified cerebral cortex using human stem cells. This groundbreaking
UK Government Allocates £30 Million To Drive Medtech Advancements In NHS 03 Oct, 2023: The UK's NHS (National Health Services) Department of Health and Social Care is encouraging Integrated Care Systems (ICSs) to submit bids for a share of